Pirjo Mustonen
Overview
Explore the profile of Pirjo Mustonen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
561
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Siponen R, Hartikainen J, Virrankorpi J, Lappalainen A, Teppo K, Halminen O, et al.
Scand Cardiovasc J
. 2025 Feb;
59(1):2467735.
PMID: 39951324
Background: Patients with atrial fibrillation (AF) are often treated with antiarrhythmic drugs (AADs) to maintain sinus rhythm and with heart rate-lowering drugs to achieve the optimal rate control. In this...
2.
Vanhanen M, Jaakkola J, Airaksinen J, Halminen O, Putaala J, Mustonen P, et al.
Gen Hosp Psychiatry
. 2025 Feb;
93:116-121.
PMID: 39946954
Objective: Patients with alcohol use disorders (AUD) often receive inferior care for somatic comorbidities. Our objective was to explore whether AUDs influence oral anticoagulant (OAC) initiation for stroke prevention among...
3.
Teppo K, Airaksinen K, Halminen O, Jaakkola J, Haukka J, Kouki E, et al.
JACC Clin Electrophysiol
. 2024 Dec;
PMID: 39708034
Background: Atrial fibrillation (AF) is a major risk factor for ischemic stroke (IS), but whether the magnitude of this risk has changed over time is unknown. Objectives: This study sought...
4.
Lappalainen A, Hartikainen J, Teppo K, Halminen O, Aro A, Siponen R, et al.
Int J Cardiol Heart Vasc
. 2024 Nov;
55:101541.
PMID: 39507295
Background: Catheter ablation is a well-established treatment to prevent atrial fibrillation (AF) and atrial flutter (AFL) recurrences and to relieve symptoms, whereas pacemaker implantation and atrioventricular node (AVN) ablation is...
5.
Salmela B, Jaakkola J, Kalatsova K, Inkovaara J, Aro A, Teppo K, et al.
Europace
. 2024 Oct;
26(10).
PMID: 39383252
Aims: Atrial fibrillation (AF) patients frequently require active rhythm control therapy to maintain sinus rhythm and reduce symptom burden. Our study assessed whether antiarrhythmic therapies (AATs) are used disproportionately between...
6.
Teppo K, Karlsson E, Kiviniemi T, Halminen O, Lehtonen O, Kouki E, et al.
Atherosclerosis
. 2024 Sep;
399:118590.
PMID: 39299822
Background And Aims: We examined temporal trends and age-related differences in the prevalence of vascular diseases and in their association with ischemic stroke (IS) risk in patients with atrial fibrillation...
7.
Kouki E, Salmela B, Aro A, Halminen O, Teppo K, Haukka J, et al.
BMJ Open
. 2024 Sep;
14(9):e080836.
PMID: 39277207
Objectives: Atrial fibrillation (AF) is associated with increased mortality. Previous studies have reported conflicting results in temporal trends of mortality after AF diagnosis. We aim to address this disparity by...
8.
Teppo K, Lip G, Airaksinen K, Halminen O, Haukka J, Putaala J, et al.
Lancet Reg Health Eur
. 2024 Aug;
43:100967.
PMID: 39171253
Background: Contemporary data have shown a decrease in the ischaemic stroke risk associated with female sex in patients with atrial fibrillation (AF). We evaluated temporal trends in the predictive value...
9.
Lehto M, Luojus A, Halminen O, Haukka J, Putaala J, Linna M, et al.
Ann Med
. 2024 Jun;
56(1):2364825.
PMID: 38873855
Background: Little is known how individual time-in-therapeutic-range (TTR) impacts the effectiveness and safety of warfarin therapy compared to direct oral anticoagulants (DOACs) in patients with atrial fibrillation (AF). Objective: To...
10.
Jyrkila H, Kaartinen K, Martola L, Halminen O, Haukka J, Linna M, et al.
Nephron
. 2024 Jun;
148(11-12):755-767.
PMID: 38861935
Introduction: Chronic kidney disease (CKD) is associated with an increased incidence of atrial fibrillation (AF). Also, patients with AF are prone to adverse kidney outcomes. We examined comorbidities and medication...